|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��Ƥ�ʼ����� |
|
�ֿ� |
| ��������������� | |
|
���̷� |
|
���� |
| PubMed | |
|
Article by |
|
Article by |
��Ƥ�ʼ������Ƶֿ����Ƶ��о���չ
���̷�, ����
�����е�������ҽԺƤ���� 310009
��Ƥ�ʼ��ز���������Ҫ��������,���Ҿ�����Ҫ�Ŀ��ס����������������Ƶ�����,�ٴ��Ϲ㷺�������������Լ����ͱ�̬��Ӧ�Լ����ȵ�����,�����ֻ��߶���Ƥ�ʼ������Ƶֿ�����������Ƥ�ʼ������Ƶֿ����Ƶ��о���չ��
�㽭ʡ��������������(2004B168)
[2] Shahidi H, Vottero A, Stratakis CA,et al. Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem Biophys Res Commun, 1999, 254:559-565.
[3] Bourgeois S, Gruol DJ, Newby RF, et al. Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis. Mol Endocrinol, 1993, 7:840-851.
[4] Farrell R J, Murphy A, Long A, el al. High multidrug resistance (Pglycoprotein 170) expression ir inflammatory bowel disease patients who fail medical therapy. Gastroenterology, 2000, 118:279-288.
[5] Shimada T, Hiwatashi N, Yamazaki H, et al. Relationship between glucocorticoid receptor and response to glucocorticoid therapy in ulcerative colitis. Dis Colon Rectum, 1997, 40:S54-S58.
[6] Bray PJ, Du B, Mejia VM, et al. Glucocorticoid resistance caused by reduced expression of the glucocorticoid receptor in cells from human vascular lesions. Arterioscler Thromb Vasc Biol, 1999, 19: 1180-1189.
[7] Cho YJ, Lee KE. Decreased glucocorticoid binding affinity to glucocorticoid receptor is important in the poor response to steroid therapy of older-aged patients with severe bronchial asthma. Allergy Asthma Proc, 2003, 24:353-358.
[8] Spahn JD, Landwehr LP, Nimmagadda S, et al. Effects of glucocorticoids on lymphocyte activation in patients with steroid-sensitive and steroid-resistant asthma. J Allergy Clin Immunol, 1996, 98:1073-1079.
[9] Ruiz M, Lind U, Gafvels M, et al. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with prinary cortisol resistance. Clin Endocrinol (Oxf), 2001, 55:363-371.
[10] Bamberger CM, Bamberger AM, de Castro M, et al. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest, 1995, 95:2435-2441.
[11] Oakley RH, Jewell CM, Yudt MR, et al. The dominant negative activity of the human glncocorticoid receptor beta isoform. Specificity and mechanisms of action. J B iol Chem, 1999, 274:27857-27866.
[12] Webster JC, Oakley RH, Jewell CM,et al. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci U S A,2001, 98:6865-6870.
[13] Honda M, Orii F, Ayabe T, et al. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology, 2000, 118:859-866.
[14] Sousa AR, Lane SJ, Cidlowski JA, et al. Glucocortieoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform. J Allergy Clin Immunol, 2000, 105:943-950.
[15] Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med, 1997, 336:1066-1071.
[16] Bantel H, Schmitz ML, Raible A, et al. Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness.FASEB J, 2002, 16:1832-1834.
[17] Takahashi E, Onda K, Hirano T, et al. Expression of c-fos, rather than c-jun or glucocorticoid-receptor mRNA, correlates with decreased glucocorticoid response of peripheral blood mononuclear cells in asthma. Int Immunopharmacol, 2002, 2:1419-1427.
[18] Bailey S, Hall AG, Pearson AD,et al. Glucocorticoid resistance and the AP-1 transcription factor in leukaemia. Adv Exp Med Biol,1999,457:615-619.
[19] Kang Kl, Meng X, Devin-Leclerc J, et al. The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorticosteroid-dependent promoter. Proc Natl Acad Sci U S A, 1999, 96:1439-1444.
[20] Bronnegard M, Boos J, Marcus C, et al. Expression of hsp90 beta messenger ribonucleic acid in patients with familial glucocorticoid resistance-correlation to receptor status. J Steroid Biochem Mol Biol,1995, 52:345-349.